Patent Expiry

Patent/Exclusivity Expiry: INPEFA

Drug
INPEFA

Other upcoming events for LXRX

Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Ef

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: INPEFA — LXRX Patent Expiry | BioSniper